Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 162

1.

Overdiagnosis, sojourn time, and sensitivity in the Copenhagen mammography screening program.

Olsen AH, Agbaje OF, Myles JP, Lynge E, Duffy SW.

Breast J. 2006 Jul-Aug;12(4):338-42.

PMID:
16848843
3.

Age-specific interval breast cancers in New South Wales and meta-analysis of studies of women aged 40-49 years.

Taylor R, Page A, Bampton D, Estoesta J, Rickard M.

J Med Screen. 2004;11(4):199-206.

PMID:
15563775
4.

Estimates of overdiagnosis of invasive breast cancer associated with screening mammography.

Morrell S, Barratt A, Irwig L, Howard K, Biesheuvel C, Armstrong B.

Cancer Causes Control. 2010 Feb;21(2):275-82. doi: 10.1007/s10552-009-9459-z. Epub 2009 Nov 6.

PMID:
19894130
5.

Estimating mean sojourn time and screening test sensitivity in breast cancer mammography screening: new results.

Weedon-Fekjaer H, Vatten LJ, Aalen OO, Lindqvist B, Tretli S.

J Med Screen. 2005;12(4):172-8.

PMID:
16417693
6.

Breast cancer incidence after the introduction of mammography screening: what should be expected?

Svendsen AL, Olsen AH, von Euler-Chelpin M, Lynge E.

Cancer. 2006 May 1;106(9):1883-90.

7.

Seventeen-years overview of breast cancer inside and outside screening in Denmark.

Domingo L, Jacobsen KK, von Euler-Chelpin M, Vejborg I, Schwartz W, Sala M, Lynge E.

Acta Oncol. 2013 Jan;52(1):48-56. doi: 10.3109/0284186X.2012.698750. Epub 2012 Sep 3.

PMID:
22943386
8.

Does educational level determine screening participation?

von Euler-Chelpin M, Olsen AH, Njor S, Jensen A, Vejborg I, Schwartz W, Lynge E.

Eur J Cancer Prev. 2008 Jun;17(3):273-8. doi: 10.1097/CEJ.0b013e3282f0c017.

PMID:
18414200
9.

Breast cancer incidence after the start of mammography screening in Denmark.

Olsen AH, Jensen A, Njor SH, Villadsen E, Schwartz W, Vejborg I, Lynge E.

Br J Cancer. 2003 Feb 10;88(3):362-5.

10.

Balancing sensitivity and specificity: sixteen year's of experience from the mammography screening programme in Copenhagen, Denmark.

Utzon-Frank N, Vejborg I, von Euler-Chelpin M, Lynge E.

Cancer Epidemiol. 2011 Oct;35(5):393-8. doi: 10.1016/j.canep.2010.12.001. Epub 2011 Jan 15.

PMID:
21239242
11.
12.

Predicting the risk of a false-positive test for women following a mammography screening programme.

Njor SH, Olsen AH, Schwartz W, Vejborg I, Lynge E.

J Med Screen. 2007;14(2):94-7.

PMID:
17626709
13.

Age specific sensitivity and sojourn time in a breast cancer screening programme (DOM) in The Netherlands: a comparison of different methods.

Brekelmans CT, Westers P, Faber JA, Peeters PH, Collette HJ.

J Epidemiol Community Health. 1996 Feb;50(1):68-71.

14.

Estimating mean sojourn time and screening sensitivity using questionnaire data on time since previous screening.

Weedon-Fekjaer H, Lindqvist BH, Vatten LJ, Aalen OO, Tretli S.

J Med Screen. 2008;15(2):83-90. doi: 10.1258/jms.2008.007071.

PMID:
18573776
15.

Participation behaviour following a false positive test in the Copenhagen mammography screening programme.

Andersen SB, Vejborg I, von Euler-Chelpin M.

Acta Oncol. 2008;47(4):550-5. doi: 10.1080/02841860801935483.

PMID:
18465321
16.

Women's patterns of participation in mammography screening in Denmark.

von Euler-Chelpin M, Olsen AH, Njor S, Vejborg I, Schwartz W, Lynge E.

Eur J Epidemiol. 2006;21(3):203-9.

PMID:
16547835
18.

A case-control study to estimate the impact of the Icelandic population-based mammography screening program on breast cancer death.

Gabe R, Tryggvadóttir L, Sigfússon BF, Olafsdóttir GH, Sigurdsson K, Duffy SW.

Acta Radiol. 2007 Nov;48(9):948-55.

PMID:
18080359
19.

[The effectiveness of population-based breast cancer screening programme].

Szynglarewicz B, Matkowski R, Kasprzak P, Kotowska J, Forgacz J, Pudełko M, Kornafel J.

Pol Merkur Lekarski. 2009 Feb;26(152):117-20. Polish.

PMID:
19388515
20.

Overdiagnosis in organised mammography screening in Denmark. A comparative study.

Jørgensen KJ, Zahl PH, Gøtzsche PC.

BMC Womens Health. 2009 Dec 22;9:36. doi: 10.1186/1472-6874-9-36.

Supplemental Content

Support Center